Cargando…
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy
BACKGROUND: Hairy cell leukemia (HCL) is a rare chronic B cell malignancy, characterized by infiltration of bone marrow, blood and spleen by typical “hairy cells” that bear the BRAFV600E mutation. However, in addition to the intrinsic activation of the MAP kinase pathway as a consequence of the BRAF...
Autores principales: | Maitre, Elsa, Cornet, Edouard, Debliquis, Agathe, Drenou, Bernard, Gravey, François, Chollet, Didier, Cheze, Stephane, Docquier, Mylène, Troussard, Xavier, Matthes, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293816/ https://www.ncbi.nlm.nih.gov/pubmed/35476232 http://dx.doi.org/10.1007/s00432-022-04010-4 |
Ejemplares similares
-
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
por: Cornet, Edouard, et al.
Publicado: (2015) -
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
por: Maitre, Elsa, et al.
Publicado: (2022) -
Variant form of hairy cell leukemia
por: Wiber, Margaux, et al.
Publicado: (2019) -
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
por: Maitre, Elsa, et al.
Publicado: (2022) -
Hairy cell leukemia 2018: Update on diagnosis, risk‐stratification, and treatment
por: Troussard, Xavier, et al.
Publicado: (2017)